Kilitch Drugs (India) Limited Cash Flow Conversion Efficiency

Latest as of September 2025: -0.025x

Kilitch Drugs (India) Limited cash flow conversion efficiency. Based on the latest financial reports, Kilitch Drugs (India) Limited (KILITCH) has a cash flow conversion efficiency ratio of -0.025x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs-66.20 Million ≈ $-715.95K USD) by net assets (Rs2.64 Billion ≈ $28.57 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Kilitch Drugs (India) Limited (2006–2025)

Cash flow conversion efficiency of Kilitch Drugs (India) Limited from 2006 to 2025. This chart illustrates how Kilitch Drugs (India) Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Kilitch Drugs (India) Limited (KILITCH) share price today for real-time trading data and today's change.

Kilitch Drugs (India) Limited Cash Flow Conversion Ratio Explained

Kilitch Drugs (India) Limited cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Kilitch Drugs (India) Limited Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Kilitch Drugs (India) Limited ranked by their cash flow conversion efficiency. Also see KILITCH market cap for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
Salasar Techno Engineering Limited NSE:SALASAR	0.024x
Maxiparts Ltd AU:MXI	0.065x
Advero Properties SOCIMI S.A. MC:YADV	0.008x
Scandinavian Astor Group AB ST:ASTOR	0.053x
Soluna Holdings Inc NASDAQ:SLNH	-0.051x
LOT VACUUM Co. Ltd KQ:083310	0.030x
AmeriServ Financial Inc NASDAQ:ASRV	0.003x
Passus S.A. WAR:PAS	0.419x

Annual Cash Flow Conversion Efficiency for Kilitch Drugs (India) Limited (2006–2025)

The table below shows the annual cash flow conversion efficiency of Kilitch Drugs (India) Limited from 2006 to 2025. Review KILITCH cash flow after capex ratio to assess how much free cash flow the company generates relative to operating cash flow.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-03-31	Rs2.00 Billion ≈ $21.68 Million	Rs175.42 Million ≈ $1.90 Million	0.088x	+10608.11%
2024-03-31	Rs1.76 Billion ≈ $19.00 Million	Rs-1.46 Million ≈ $-15.82K	-0.001x	-104.85%
2023-03-31	Rs1.51 Billion ≈ $16.28 Million	Rs25.86 Million ≈ $279.64K	0.017x	-58.34%
2022-03-31	Rs1.40 Billion ≈ $15.17 Million	Rs57.83 Million ≈ $625.41K	0.041x	-88.31%
2021-03-31	Rs1.29 Billion ≈ $14.00 Million	Rs456.59 Million ≈ $4.94 Million	0.353x	+1034.35%
2020-03-31	Rs1.20 Billion ≈ $13.03 Million	Rs37.45 Million ≈ $405.02K	0.031x	+1216.09%
2019-03-31	Rs1.23 Billion ≈ $13.32 Million	Rs2.91 Million ≈ $31.46K	0.002x	-81.28%
2018-03-31	Rs1.13 Billion ≈ $12.19 Million	Rs14.23 Million ≈ $153.90K	0.013x	+13.89%
2017-03-31	Rs1.01 Billion ≈ $10.94 Million	Rs11.21 Million ≈ $121.28K	0.011x	-93.01%
2016-03-31	Rs1.09 Billion ≈ $11.75 Million	Rs172.33 Million ≈ $1.86 Million	0.159x	+349.49%
2015-03-31	Rs1.20 Billion ≈ $12.96 Million	Rs-76.18 Million ≈ $-823.90K	-0.064x	+75.42%
2014-03-31	Rs1.20 Billion ≈ $13.00 Million	Rs-310.84 Million ≈ $-3.36 Million	-0.259x	-2155.68%
2013-03-31	Rs1.19 Billion ≈ $12.88 Million	Rs14.97 Million ≈ $161.93K	0.013x	+104.95%
2012-03-31	Rs1.16 Billion ≈ $12.50 Million	Rs-293.49 Million ≈ $-3.17 Million	-0.254x	-217.16%
2011-03-31	Rs858.72 Million ≈ $9.29 Million	Rs186.05 Million ≈ $2.01 Million	0.217x	+3.92%
2010-03-31	Rs740.88 Million ≈ $8.01 Million	Rs154.46 Million ≈ $1.67 Million	0.208x	+27.83%
2009-03-31	Rs643.97 Million ≈ $6.96 Million	Rs105.03 Million ≈ $1.14 Million	0.163x	+120.74%
2008-03-31	Rs513.18 Million ≈ $5.55 Million	Rs-403.48 Million ≈ $-4.36 Million	-0.786x	-189.85%
2007-03-31	Rs135.84 Million ≈ $1.47 Million	Rs118.87 Million ≈ $1.29 Million	0.875x	+22.51%
2006-03-31	Rs116.74 Million ≈ $1.26 Million	Rs83.39 Million ≈ $901.79K	0.714x	--

About Kilitch Drugs (India) Limited

NSE:KILITCH India Drug Manufacturers - Specialty & Generic

Market Cap

$78.99 Million

Rs7.30 Billion INR

Market Cap Rank

#19941 Global

#1093 in India

Share Price

Rs208.91

Change (1 day)

+3.35%

52-Week Range

Rs124.45 - Rs379.50

All Time High

Rs487.85